Global Viral Clearance Market Report 2022: Possibility of Cell Culture Contamination Driving Adoption and Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Sep 23, 2022--

The "Global Viral Clearance Market (2022-2027) by Method, Product, Applications, End-user, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Viral Clearance Market is estimated to be worth USD 532.9 million in 2022, and is expected to reach USD 1,114.46 million by 2027, growing at a CAGR of 15.9%.

Market Segmentation

The Global Viral Clearance Market is segmented based on Method, Product, Applications, End-user, and Geography.

• By Method, the market is classified into Pasteurization and Solvent Detergent Method.
• By Product, the market is classified into Kits & Reagents, Services, and Viral Inactivation Systems & Accessories.
• By Applications, the market is classified into Blood & Blood Products, Cellular & Gene Therapy Products, Stem Cell Products, Tissues & Tissue Products, and Vaccines & Therapeutic.
• By End-user, the market is classified into Academic Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
• By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Countries Studied

• America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
• Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
• Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
• Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

The Competitive Quadrant

The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

• The report presents a detailed Ansoff matrix analysis for the Global Viral Clearance Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
• The Global Viral Clearance Market is analyzed using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
• Based on the SWOT analysis conducted on the industry and industry players, suitable strategies have been devised for market growth.

Why Buy This Report?

• The report offers a comprehensive evaluation of the Global Viral Clearance Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel within the industry.
• The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
• The report also includes the regulatory scenario within the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules & regulations imposed on this sector across various geographies.
• The report also contains competitive analysis using 'Positioning Quadrants'; a proprietary competitive positioning tool.

Market Dynamics

Drivers

• Growing Government Support for Pharmaceutical & Biotechnology Industries
• Possibility of Cell Culture Contamination
• Increase in the Prevalence of Chronic Diseases
• Rising Number of New Drug Launches

Restraints

• High Costs Associated With the Manufacture of Biosimilar Products
• Time-intensive Drug Development Process

Opportunities

• Increasing Pharmaceutical Outsourcing
• Strong R&D Investments in the Life Sciences Industry

Challenges

• Dearth of Skilled Professionals
• High Degree of Consolidation to Act as a Major Barrier for New Entrants

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics

5 Market Analysis

6 Global Viral Clearance Market, by Method

7 Global Viral Clearance Market, by Product

8 Global Viral Clearance Market, by Applications

9 Global Viral Clearance Market, by End User

10 Americas' Viral Clearance Market

11 Europe's Viral Clearance Market

12 Middle East and Africa's Viral Clearance Market

13 APAC's Viral Clearance Market

14 Competitive Landscape

15 Company Profiles

16 Appendix

Companies Mentioned

• Agilent Technologies, Inc.
• Avance Biosciences Inc.
• Becton, Dickinson and Co.
• Bio-Rad Laboratories, Inc.
• Charles River Laboratories International, Inc.
• Clean Cells Inc.
• Danaher Corp.
• Eppendorf SE
• Eurofins Scientific SE
• F. Hoffmann-La Roche Ltd.
• General Electric Co.
• HiMedia Laboratories
• Lonza Group AG
• Merck Group
• Novogene Co. Ltd.
• Parker Hannifin Corp.
• Pfizer Inc.
• PromoCell GmbH
• Rad Source Technologies, Inc.
• Sartorius AG

For more information about this report visit https://www.researchandmarkets.com/r/f091w9

View source version on businesswire.com:https://www.businesswire.com/news/home/20220923005377/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: INFECTIOUS DISEASES BIOTECHNOLOGY HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2022.